A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
The Betfred Super League fixture between Wigan Warriors and Widnes Vikings scheduled for this Friday (February 24) has been postponed.
Around 800 properties in the North West remain without electricity, as engineers from Electricity North West work to restore power.
Wayne Rooney has announced he is staying at Manchester United in a statement released on Thursday.